Medtronic plc announced four executive appointments to further its commitment to become the global leader in healthcare technology. Bob Hopkins as head of global strategy, effective November 15, 2021; Mei Jiang as new global digital innovation leader, effective November 15, 2021; Harry Skip Kiil as President of the Cranial and Spinal Technologies (CST) Operating Unit, effective January 4, 2022 and Mira Sahney as President of the Pelvic Health Operating Unit, effective December 6, 2021. Bob Hopkins comes from Bank of America Merrill Lynch, where he has served as Managing Director since 2008, covering the medical technology industry, including Medtronic. Hopkins has worked with the medtech industry for more than 25 years. In his role, Hopkins will partner with the company?s senior leadership in the areas of strategy, business development, capital deployment and investor communication. His broad, global perspective, including insights into the companies, technologies, and trends impacting healthcare and the medical technology industry will help Medtronic continue to navigate the rapidly evolving industry. Mei Jiang will join the company from Iron Mountain, where she served as Senior Vice President, Global Head of Innovation, Product & Solutions. Prior to Iron Mountain, Jiang spent six years at HP, where she most recently served as Head of Digital Innovation & Business Transformation, and Cisco, where she was Founder/CEO of a management consulting startup. Jiang is also a member of the Forbes Technology Council and founding member of Chief. In her new role, Jiang will work with leaders across the organization to test, expand, and accelerate the company?s data, digitization, and AI strategies, globally. This work includes using data and AI to enhance internal processes, as well as establishing new business models leveraging existing capabilities and technologies. She'll transform the company's core markets and businesses using the insights of data and AI, as well as establish enterprise-wide capabilities and resources needed to support this transformation. Harry Skip Kiil will join the company from Smith+Nephew, where he was President of the Global Orthopaedics business, responsible for the company's reconstructive arthroplasty, robotics, trauma, and extremities businesses. Kiil has extensive experience in spine and orthopaedics, deep understanding of international markets, and expertise in leveraging technology to create and deliver an integrated ecosystem at scale. Previously, Kiil was Executive Vice President and President of Global Commercial Operations at NuVasive Inc. He also served as Surgical Head, Europe, Middle East, Africa, and Russia, in the Alcon Eye Care Division of Novartis Corporation. Before joining Alcon, Kiil spent 12 years with Stryker Corporation, where he held several leadership roles, including Vice President and General Manager for Europe, and General Manager for Japan. In his new role, Kiil will be responsible for driving innovation and delivering therapies to markets around the world more quickly and effectively and cultivating a strong culture within Cranial and Spinal Technologies. Mira Sahney brings more than 25 years of executive leadership experience in the development and commercialization of innovative medical technologies across gynecology, ENT, orthopaedics, and medical robotics. Sahney will leverage her deep background in mergers and acquisitions, product marketing, and commercial strategy to lead the Pelvic Health operating unit into the increasingly competitive future of the incontinence market. Sahney joins the company from Hyalex Orthopaedics, where she has served as Chief Executive Officer and a member of the Board of Directors since 2017. In this role, she formed its investment syndicate and built a world-class organization. Prior to Hyalex, Sahney held a number of business leadership roles with Smith+Nephew, including Senior Vice President and General Manager of ENT and Gynecology. She also led the sale of Smith+Nephew's gynecology business to Medtronic in 2016. Before her tenure with Smith+Nephew, Sahney was President, CEO and Co-Founder of Myomo Inc. Her early career included a variety of supply chain, engineering, strategy, product management, product development, research and software roles at Flow International, the BMW Group and Boeing. In her new role, Sahney will be responsible for driving innovation and expanding access to more patients around the world, while cultivating a strong culture within Pelvic Health.